Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KRTX

Karuna Therapeutics (KRTX) Stock Price, News & Analysis

Karuna Therapeutics logo

About Karuna Therapeutics Stock (NASDAQ:KRTX)

Key Stats

Today's Range
$329.83
$329.83
50-Day Range
$313.97
$329.83
52-Week Range
$158.38
$329.99
Volume
5 shs
Average Volume
832,048 shs
Market Capitalization
$12.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KRTX Stock News Headlines

NEW LAW: Congress Approves Setup For Digital Dollar?
Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor Green, it's a bill that contains "the entire setup, groundwork and infrastructure to move from cash to digital currency."tc pixel
Bristol Myers to Purchase Karuna
See More Headlines

KRTX Stock Analysis - Frequently Asked Questions

Karuna Therapeutics, Inc. (NASDAQ:KRTX) posted its earnings results on Thursday, February, 22nd. The company reported ($3.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.65) by $0.36. The firm's revenue was down 100.0% on a year-over-year basis.

Karuna Therapeutics (KRTX) raised $70 million in an initial public offering on Friday, June 28th 2019. The company issued 4,400,000 shares at $15.00-$17.00 per share. Goldman Sachs, Citigroup and Wells Fargo Securities served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Karuna Therapeutics investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Palo Alto Networks (PANW), Salesforce (CRM) and Netflix (NFLX).

Company Calendar

Last Earnings
2/22/2024
Today
10/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KRTX
CIK
1771917
Fax
N/A
Employees
339
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($11.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$433.68 million
Net Margins
N/A
Pretax Margin
-66,209.48%
Return on Equity
-31.63%
Return on Assets
-30.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.31
Quick Ratio
19.31

Sales & Book Value

Annual Sales
$654 thousand
Price / Sales
19,239.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$33.24 per share
Price / Book
9.92

Miscellaneous

Outstanding Shares
38,148,000
Free Float
33,157,000
Market Cap
$12.58 billion
Optionable
Optionable
Beta
1.18

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:KRTX) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners